Complete remission of sclerodermatous cutaneous graft‐versus‐host disease after low‐dose interleukine‐2 treatment. (26th August 2020) - Weiss, M.; de Masson, A.; Robin, M.; Peffault de Latour, R.; Bagot, M.; Socié, G.; Bouaziz, J.‐D.